| ACE-tRNAs | Anticodon engineered transfer RNAs |
| AT | Ataxia telangiectasia |
| CF | Cystic fibrosis |
| CFTR | Cystic fibrosis transmembrane conductance regulator |
| DAPI | 4′,6-diamidino-2-phenylindole |
| DMD | Duchenne muscular dystrophy |
| FTR cells | Fisher rat thyroid cells |
| GFP | Green Fluorescent Protein |
| HS | Hurler’s syndrome |
| IFD | Induced Fit Docking |
| MD | Molecular Dynamics |
| MM-GBSA | molecular mechanics /generalized Born and surface area continuum solvation |
| NMD | Nonsense-mediated mRNA decay |
| NonSups | Nonsense suppressors |
| pFLuc-wt | Plasmid firefly luciferase-wild type |
| PTC | Premature stop codon |
| PTC124 | Ataluren or 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl] benzoic acid |
| QPLD | Quantum Polarized Ligand Docking |
| RF | Release factor |
| RLuc | Renilla reniformis luciferase |
| TRIDs | Translational Readthrough-Inducing Drugs |
| Upf1 | Regulator of nonsense transcripts 1 |
| USH | Usher’s syndrome |
| YFP | Yellow fluorescent protein |